Millions of people, particularly in rural and low-income communities, lack access to affordable screening for diabetic retinopathy and anemia. Traditional diagnosis often requires costly retinal equipment, laboratory tests, and specialized healthcare professionals that may not be available in remote areas. This limited accessibility can result in late detection and serious, preventable health complications. There is a need for an affordable and easy-to-use screening solution that can extend early detection beyond clinical settings. SmartEye AI addresses this by using AI-based eye image analysis to provide accessible preliminary screening through internet-connected devices.